Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$43,641,264
+$2,996,629 QoQ
Shares Held
36,385
-17.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
#584
of 4,604 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 41%
Shared 0%
None 59%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COLDSTREAM CAPITAL MANAGEMENT INC holds $126,380,504 across 14 Drug Manufacturers - General names. LLY ranks #1 (34.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
36,385 | $43,641,264 | |
| 2 | JNJ |
Johnson & Johnson
|
92,571 | $23,510,256 | |
| 3 | ABBV |
AbbVie Inc.
|
73,209 | $18,422,312 | |
| 4 | MRK |
Merck & Co., Inc.
|
123,237 | $15,835,954 | |
| 5 | AMGN |
Amgen Inc
|
19,733 | $7,145,713 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
35,562 | $4,492,903 | |
| 7 | NVS |
Novartis AG
|
17,467 | $2,737,428 | |
| 8 | PFE |
Pfizer Inc
|
110,237 | $2,654,506 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,641,264 | 36,385 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $40,644,635 | 44,190 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $46,824,885 | 43,571 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $32,364,934 | 42,418 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $26,316,153 | 33,759 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $19,432,836 | 23,529 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $17,950,544 | 23,252 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,544,062 | 23,189 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $21,486,478 | 23,732 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $18,492,109 | 23,770 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $13,724,851 | 23,545 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $12,596,235 | 23,451 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $7,115,364 | 15,172 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $5,098,413 | 14,846 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,340,898 | 14,599 | Shares | Sole | 2023-01-10 | |
| 2022-06-30 | $4,577,154 | 14,117 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,500,014 | 12,222 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,696,099 | 13,381 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,826,219 | 7,904 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,849,472 | 8,058 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,488,581 | 7,968 | Shares | Sole | 2021-06-16 | |
| 2020-12-31 | $1,357,811 | 8,042 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,083,654 | 7,321 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,247,275 | 7,597 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $692,074 | 4,989 | Shares | Sole | 2020-05-27 | |
| No filing history on record for this holder in this stock. | ||||||